G. Harms

994 total citations
27 papers, 806 citations indexed

About

G. Harms is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, G. Harms has authored 27 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in G. Harms's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Pneumonia and Respiratory Infections (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). G. Harms is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Pneumonia and Respiratory Infections (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). G. Harms collaborates with scholars based in Netherlands, United States and Malaysia. G. Harms's co-authors include Mj Hardonk, J Koudstaal, Wim Timens, Harry van Goor, Lisa Ley, Anke van den Berg, M. J. Hardonk, Tjasso Blokzijl, Joost Kluiver and S Poppema and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Oncogene.

In The Last Decade

G. Harms

27 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Harms Netherlands 16 338 221 179 106 106 27 806
Charles Schick United States 11 425 1.3× 156 0.7× 412 2.3× 53 0.5× 179 1.7× 12 1.0k
Eugene Dempsey Ireland 15 318 0.9× 163 0.7× 119 0.7× 58 0.5× 79 0.7× 24 686
Andreas Klein Germany 20 445 1.3× 131 0.6× 160 0.9× 49 0.5× 222 2.1× 39 932
Lucy East United Kingdom 7 374 1.1× 310 1.4× 172 1.0× 38 0.4× 97 0.9× 7 835
Katja Fiedler Germany 12 584 1.7× 287 1.3× 242 1.4× 44 0.4× 127 1.2× 16 978
Y. Matsuda Japan 19 329 1.0× 165 0.7× 70 0.4× 134 1.3× 229 2.2× 38 989
Dianzhong Luo China 16 458 1.4× 222 1.0× 250 1.4× 101 1.0× 105 1.0× 27 946
Marika Christodoulou United Kingdom 4 422 1.2× 288 1.3× 460 2.6× 57 0.5× 319 3.0× 4 1.2k
Sang-Jin Lee South Korea 22 599 1.8× 293 1.3× 147 0.8× 106 1.0× 272 2.6× 58 1.1k
Angela Holder United Kingdom 16 361 1.1× 171 0.8× 87 0.5× 174 1.6× 91 0.9× 35 919

Countries citing papers authored by G. Harms

Since Specialization
Citations

This map shows the geographic impact of G. Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Harms more than expected).

Fields of papers citing papers by G. Harms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Harms. The network helps show where G. Harms may publish in the future.

Co-authorship network of co-authors of G. Harms

This figure shows the co-authorship network connecting the top 25 collaborators of G. Harms. A scholar is included among the top collaborators of G. Harms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Harms. G. Harms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Mindy, Kirsten van Lom, G. Harms, et al.. (2008). miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC /miR‐155 expression. The Journal of Pathology. 215(1). 13–20. 92 indexed citations
2.
Visser, Lydia, et al.. (2007). CD4+CD26 - T Cell Population in Classical Hodgkin Lymphoma Displays a Distinctive Regulatory T Cell Population.. Blood. 110(11). 384–384. 3 indexed citations
3.
Kluiver, Joost, Anke van den Berg, Debora de Jong, et al.. (2006). Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene. 26(26). 3769–3776. 114 indexed citations
4.
Kluiver, Joost, L. de Visser, G. Harms, et al.. (2006). Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis. The Journal of Pathology. 209(4). 474–483. 23 indexed citations
5.
Breukels, Mijke A., et al.. (2005). Complement Dependency of Splenic Localization of Pneumococcal Polysaccharide and Conjugate Vaccines. Scandinavian Journal of Immunology. 61(4). 322–328. 19 indexed citations
6.
Harms, G., Tjasso Blokzijl, Arjan Diepstra, et al.. (2005). High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma. Journal of Clinical Pathology. 58(5). 520–524. 18 indexed citations
7.
Ásgeirsdóttir, Sigrídur A., et al.. (2002). Analysis ofin VivoEndothelial Cell Activation Applying RT‐PCR following Endothelial Cell Isolation by Laser Dissection Microscopy. Annals of the New York Academy of Sciences. 973(1). 586–589. 5 indexed citations
8.
Harms, G., et al.. (2000). Metastatic Non-Small Cell Lung Carcinoma With Involvement of Extremity Musculature: Case Report and Review of the Literature. Mayo Clinic Proceedings. 75(12). 1333–1337. 7 indexed citations
9.
Leemans, R., G. Harms, G T Rijkers, & Wim Timens. (1999). Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine. Clinical & Experimental Immunology. 117(3). 596–604. 40 indexed citations
10.
Peters, Frans, Shanthi Ganesh, Ernst J. Kuipers, et al.. (1998). Epithelial Cell Proliferative Activity of Barrett's Esophagus (Methodology and Correlation with Traditional Cancer Risk Markers). Digestive Diseases and Sciences. 43(7). 1501–1506. 11 indexed citations
12.
Harms, G., Mj Hardonk, & Wim Timens. (1996). In vitro complement-dependent binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle. Infection and Immunity. 64(10). 4220–4225. 40 indexed citations
13.
Alaibac, Mauro, Antonio Daga, G. Harms, et al.. (1993). Molecular analysis of the γδ T‐cell receptor repertoire in normal human skin and in Oriental Cutaneous Leishmaniasis. Experimental Dermatology. 2(3). 106–112. 15 indexed citations
14.
Harms, G. & M. J. Hardonk. (1989). Specific demonstration of ribonucleic acid by chemical bromination and immunohistochemistry.. Journal of Histochemistry & Cytochemistry. 37(4). 479–485. 2 indexed citations
15.
Goor, Harry van, G. Harms, Peter O. Gerrits, et al.. (1988). Immunohistochemical antigen demonstration in plastic-embedded lymphoid tissue.. Journal of Histochemistry & Cytochemistry. 36(1). 115–120. 28 indexed citations
16.
Harms, G., U. Laukamm-Josten, Ulrich Bienzle, & I. Guggenmoos-Holzmann. (1987). Risk factors for HIV infection in german i.v. drug abusers. Journal of Molecular Medicine. 65(8). 376–379. 6 indexed citations
17.
Maes, Frédéric & G. Harms. (1986). Neural coding of salt taste quality in the blowflyCalliphora vicina. Journal of Comparative Physiology A. 159(1). 75–88. 12 indexed citations
18.
Harms, G., Harry van Goor, J Koudstaal, Lisa Ley, & Mj Hardonk. (1986). Immunohistochemical demonstration of DNA-incorporated 5-bromodeoxyuridine in frozen and plastic embedded sections. Histochemistry and Cell Biology. 85(2). 139–143. 85 indexed citations
19.
Harms, G., et al.. (1986). Studies on the Mechanism of Binding and Uptake of Immune Complexes by Various Cell Types of Rat Liver in Vivo. Scandinavian Journal of Immunology. 23(1). 127–133. 21 indexed citations
20.
Harms, G., et al.. (1985). A histochemical study about the involvement of rat liver cells in the uptake of heterologous immune comples from the circulation. Histochemistry and Cell Biology. 82(5). 477–482. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026